baber/WOPTO huggingface dataset:
Patent NZ-514945-A (NZ)
Title: Method and apparatus for the continuous biocatalytic conversion of aqueous solutions, having one or more degassing stages
Inventor: PAJUNEN ESKO JUHANI
IPC: C12M1/40
Filed: 2000-04-20
Abstract: A method and apparatus for continuous biocatalytic conversion of aqueous solutions in a reactor, having one or more converting/degassing stages in parallel or serial interconnection, each converting/degassing stage comprising a bioreactor and a degassing device in serial interconnection.  In a first process step, an aqueous solution containing biocatalytically convertible material is fed in continuous flow to the inlet of the bioreactor where it is contacted with a biocatalyst, and where in a second process step the biocatalytically-converted solution is transferred from an outlet of the bioreactor to an inlet of the degassing device.  The converted solution is at least partially degassed and, at least part of the degassed solution leaving the outlet of the last degassing device is fed to the inlet of the first bioreactor, in a continuous flow.
Patent NZ-522910-A (NZ)
Title: Graded electric field insulation system for dynamoelectric machine
Inventor: YOUNSI A KARIM
IPC: H02K3/04
Filed: 2001-09-06
Abstract: There is disclosed a groundwall insulation system for use in dynamoelectric machines carrying voltages above 4 kV and preferably in the order of 13.8 kV, or higher. The groundwall insulation comprises two layers of insulation wound onto the conductors of the high voltage winding. The first layer of insulation has a first permittivity that is greater then the permittivity of the second layer of insulation wound onto the first layer of insulation. As a consequence, at the juncture between the first and second layers there is a sharp increase in the electric field profile as seen through the groundwall insulation. This step increase in the electric field profile results in the electric field adjacent the conductor having a maximum magnitude that is less than that normally experienced by insulation systems in the past. By reducing the maximum magnitude of the local electric field profile within the groundwall insulation the life of the insulation and hence the electrical conductor is improved while at the same time permitting a reduction in the thickness of the groundwall insulation.
Patent NZ-525529-A (NZ)
Title: Non-flammable ternary cleaning solvent
Inventor: FITZGERALD JAMES M
IPC: C11D7/50
Filed: 2003-04-30
Abstract: A non-flammable ternary liquid cleaner, comprising: i) A first solvent being a hydrofluorocarbon. ii) A second solvent being a dichloroethylene iii) A third solvent being a hydrochlorofluorocarbon having low flammability The first solvent is present in a concentration of 10 % to 80 % by weight, the second solvent in present in a concentration of 10 % to 60 % by weight and the third solvent is present in a concentration of 10 % to 40 % by weight of the cleaner.
Patent NZ-531890-A (NZ)
Title: Ester compound and medicinal use thereof
Inventor: HAGIWARA ATSUSHI
IPC: A61K31/5375
Filed: 2003-02-28
Abstract: Ester compounds represented by the formula (1) are disclosed. These compounds are useful as an MTP (microsomal triglyceride transfer protein) inhibitor. They are also useful as agents for the treatment or prophylaxis of hyperlipidemia, arteriosclerosis, coronary artery diseases, obesity, diabetes or hypertension.
Patent NZ-531929-A (NZ)
Title: Use of nateglinide as a hypoglycemic agent for treating impaired glucose metabolism
Inventor: GUITARD CHRISTIANE
IPC: A61P27/02
Filed: 2000-12-04
Abstract: Nateglinide can be used in the manufacture of a medicament for subjects with IGM for the prevention or delay of progression to overt diabetes mellitus type 2, the prevention, reduction or delay in onset of a condition selected from the group consisting of increased microvascular complications, increased cardiovascular morbidity, excess cerebrovascular diseases; increased cardiovascular mortality and sudden death; and other metabolic disturbances that are associated with IGM. Preferably the medicament comprises a dosage of 30mg or 60mg of nateglinide.
Patent NZ-534682-A (NZ)
Title: Polymer coating for medical devices
Inventor: RYPACEK FRANTISEK
IPC: A61L33/00
Filed: 2003-02-14
Abstract: Coatings are provided in which surfaces may be activated by covalently bonding a silane derivative (A) to the metal surface, covalently bonding a lactone polymer (B) to the silane derivative by in situ ring opening polymerization, and depositing at least one layer of a polyester (C) on the bonded lactone. Biologically active agents may be deposited with the polyester layers. Such coated surfaces may be useful in medical devices, in particular stents.
Patent NZ-535395-A (NZ)
Title: Precise plant breeding using plant DNA border like sequences instead of Agrobacterium borders
Inventor: ROMMENS CAIUS M T
IPC: A23L19/18
Filed: 2003-02-20
Abstract: Disclosed is a method of modifying a trait of a selected plant by stably integrating only a desired polynucleotide into the genome of the plant, comprising the steps of: (a) transforming the selected plant with the desired polynucleotide, wherein: (i) the desired polynucleotide consists essentially of a nucleic acid sequence that is native to the selected plant, native to a plant from the same species as the selected plant, or native to a plant that is sexually interfertile with said selected plant, and wherein the desired polynucleotide is flanked by at least one border-like sequence that comprises the sequence SEQ ID NO: 93; (ii) the desired polynucleotide does not contain DNA that is not from: (1) the selected plant species or (2) a plant that is sexually compatible with the selected plant species; and (iii) the at least one border-like sequence does not comprise a nucleotide sequence that is identical in nucleotide sequence to an Agrobacterium TDNA border sequence; (b) selecting one or more plant cells from the plant transformed by step (a) that comprise only the desired polynucleotide in their genome; and (c) obtaining at least one stably transformed plant from the one or more selected transformed plant cells, wherein the transformed plant contains only the desired polynucleotide stably integrated into its genome and wherein the stably transformed plant exhibits a trait that is modified in comparison to the selected plant.
Patent NZ-535430-A (NZ)
Title: Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
Inventor: VERBEUREN TONY
IPC: C07C69/157
Filed: 2003-04-04
Abstract: A combination of a compound of formula (I), optionally in the form of an optical isomer or one of its pharmaceutically acceptable salts, and aspirin, or one of its pharmaceutically acceptable salts is disclosed. A pharmaceutical composition comprising the said combination of the compound of formula (I) with aspirin is suitable for use in the treatment of atherothrombotic illnesses involving the activation of TP receptors and/or the formation of metabolites and also in the treatment of consequences of those illnesses.
Patent NZ-536698-A (NZ)
Title: Detonative cleaning apparatus
Inventor: AARNIO MICHAEL J
IPC: F27D25/00
Filed: 2004-11-19
Abstract: Methods and apparatus are provided for cleaning a surface within a vessel. A fuel/oxidizer charge is provided within a combustion conduit. An initial deflagration commenced in a first portion of the charge produces a final detonation at least in another portion of the charge to expel a shockwave from the conduit which impinges upon the surface. The deflagration-to-detonation transition may be encouraged by mechanical enhancements and/or by making the first charge portion more detonable than the second.
Patent NZ-537991-A (NZ)
Title: Embossable and writable multilaminate backing construction
Inventor: AUDETT JAY DOUGLAS
IPC: A61K31/485
Filed: 2003-08-22
Abstract: A backing construction for a transdermal drug delivery system. The construction comprises: (a) an outer layer comprising an embossable and writable material; (b) a tie layer, the tie layer disposed on the skin proximal surface of the outer layer; and (c) a base layer disposed on the skin proximal surface of the tie layer.
Patent NZ-539539-A (NZ)
Title: HIV gp41 c-terminal peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties
Inventor: XIE DONG
IPC: C07K14/16
Filed: 2003-09-23
Abstract: Disclosed are gp41 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, gp41 derivatives having inhibiting activity against human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) with enhanced duration of action for the treatment of the respective viral infections.
Patent NZ-540199-A (NZ)
Title: Method and apparatus for cleaning fluids
Inventor: SMITH ROBERT CARRINGTON
IPC: C10M175/00
Filed: 2003-10-29
Abstract: Apparatus (10) for cleaning fluids such as oils comprising an inlet (12) for fluid to be cleaned, a heating unit (21) for heating the fluid, a centrifugal cleaner (24), a vacuum dehydration unit (26), a holding tank (11) and a fluid outlet (40). A first valve (13) controls communication between a first pump (20) and the inlet (12) or holding tank (11) to pump fluid from the inlet (12) or holding tank (11) to the heating unit (21) for conveyance to the centrifugal cleaner (24), the outlet of which is connected to the vacuum dehydration unit (26) and a second valve (37) controls communication between a second pump (35) and tank (11) and outlet (40) to either enable fluid to be recirculated back to the tank (11) or supplied to the outlet (40).
Patent NZ-541276-A (NZ)
Title: Briquetting process for moisture-containing bituminous and sub-bituminous coal
Inventor: KALB GEORGE WILLIAM
IPC: C10L5/24
Filed: 2004-02-11
Abstract: A process and system is provided for briquetting particulate matter such as moisture-containing bituminous and sub-bituminous coal. This process includes partially drying the particulate matter and feeding, the partially dried particulate matter to a briquetting apparatus (38) under conditions such that water vapour is released from the particulate matter during feeding. The particulate matter is passed through briquette forming rollers (44, 46) to form briquettes (47). The released water vapour substantially displaces or prevents the ingress of a large proportion of other gaseous components from the atmosphere surrounding and/or intermixed with the particulate matter. The particulate matter that is fed to the briquetting apparatus is surrounded by and intermixed with a gaseous component containing 70 to 100 % by volume of water vapour at the point where it enters the briquette-forming part of the briquetting apparatus, such that when the particulate matter is compressed during briquette formation, the water vapour liquefies and the pressure build-up of gaseous material in the thus-formed briquettes is minimised. This reduction in the pressure build-up of gaseous components also acts to reduce blow-back of gases as the coal fines are being formed into briquettes.
Patent NZ-543646-A (NZ)
Title: C1 inhibitor with short half-life for transient treatment
Inventor: NUIJENS JOHANNES HENRICUS
IPC: A61K38/57
Filed: 2004-05-14
Abstract: Provided is the use of recombinant Cl inhibitor CIINH with a half-life which is less than 60% of the half-life of plasma derived CIINH, wherein the half-life is shortened by the presence of more terminal galactose, N-acetylglucosamine, mannose, fucose or phosphomannose moieties than on the plasma-derived CIINH, for the preparation of a medicament for the transient treatment of an individual suffering from or susceptible to a condition or disease which is associated with an absolute or relative deficiency of functional CIINH, wherein said condition or disease is selected from the group consisting of: acquired angioedema (AAE), hereditary angioedema (HAE), sepsis, septic shock, acute respiratory distress syndrome (ARDS), multiple organ failure (MOF), preeclampsia, vascular leakage syndrome (VLS), graft versus host disease (GVDH), severe burns, thermal trauma, rheumatoid arthritis, systemic lupus erythematosus, meningitis, cardio-pulmonary bypass(CPB), extra corporal circulation (ECC) and (hyper) acute graft rejection. Also provided is similar use for ischemic reperfusion injury.
Patent NZ-547435-A (NZ)
Title: Methods and devices for minimally invasive spinal fixation element placement
Inventor: ANDERSON DAVID GREG
IPC: A61B17/00
Filed: 2004-11-29
Abstract: A percutaneous access device (112) for introducing a spinal fixation element into a patient's body is disclosed. The device has an elongate, generally cylindrical tube adapted for percutaneous delivery to mate to a spinal implant (70) and including proximal and distal ends. A lumen extends between the ends of the tube and is adapted to transport a spinal fixation element in a first orientation parallel to a longitudinal axis of the lumen, and to deliver the spinal fixation element into a spinal anchor site in a second orientation substantially parallel to a patient's spinal column. There is at least one sidewall opening extending from the distal end of the tube for facilitating transition of a spinal fixation element from the first orientation to the second orientation.
Patent NZ-549014-A (NZ)
Title: Two wire circuit for a laser pendulum level
Inventor: SERGYEYENKO OLEKSIY P
IPC: G01C15/00
Filed: 2005-02-08
Abstract: A laser switch control circuit for a laser leveler is disclosed. The laser switch control comprising: (a) a switch mounted on a housing in connection with a power source, where the switch has a first position and a second position; (b) a diode bridge mounted on a pendulum; (c) a plurality of lasers mounted on the pendulum and electrically coupled to the diode bridge; (d) a first wire extending from the switch to the diode bridge; and (e) a second wire extending from the switch to the diode bridge. Input current from the switch passes through the first wire to the diode bridge and to one of the plurality of lasers when the switch is in the first position, wherein input current from the switch passes through the second wire through the diode bridge and to all of the plurality of lasers when the switch is in the second position.
Patent NZ-552501-A (NZ)
Title: Novel cyclic aminobenzoic acid derivative
Inventor: NOMURA MASAHIRO
IPC: A61K31/427
Filed: 2005-08-11
Abstract: The disclosure relates to cyclic amino benzoic acid derivatives of formula (1) which are effective in therapy of lipid metabolism abnormality, diabetes and the like as a human peroxisome proliferators-activated receptor (PPAR) agonist, in particular, as an agonist against human PPAR-alpha isoform, and addition salts thereof, and pharmaceutical compositions containing these compounds, wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-554229-A (NZ)
Title: Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
Inventor: POETTER KARL
Filed: 2005-12-09
Abstract: Provided is a bead set for detecting a strain of HPV and/or for differentiating between two or more strains of HPV, wherein the bead set comprises a plurality of subsets of beads wherein:(a) the beads of each subset are homogenous with respect to size; (b) the beads within each subset are coupled to a nucleic acid capture probe which binds to an HPV strain-specific region of an HPV genome wherein the HPV strain is selected from strains 6, 11, 16, 18,31,33,35,39,45,51,52,56,58,59,66 and 68 and the capture probes consist of specified sequences; (c) the capture probe on each bead is labelled with the same label with each subset of beads having a different fluorescent intensity to create a heterogeneous mixture of beads based on fluorescent intensity; and (d) at least two subsets of beads are mixed together to produce a bead set, wherein the subset identity and therefore the strain of HPV is identified by flow cytometry based on size, fluorescent intensity and sequence discrimination. Further provided are methods of preparing the bead set and in vitro diagnosis using the bead set.
Patent NZ-570213-A (NZ)
Title: Device for treating snoring by passing the device through the tongue and anchoring it under and at the back of the tongue
Inventor: SANDERS IRA
IPC: A61F5/56
Filed: 2007-02-06
Abstract: Methods and devices to prevent or treat sleep apnea and snoring. One aspect of this invention is a tongue retractor (LTR) that indirectly retracts tongue base by its implant site in the frenulum area. This simplifies the insertion, adjustment and maintenance of the device. Another aspect of this invention describes a highly localized and fully implantable LTR that is inserted into the base of tongue to stiffen lax surface mucosa or mechanically couple it to internal tongue structures. Another aspect of this invention is an LTR inserted in or around the pharyngoglossal fold. This site allows retraction and stiffening of tongue base tissue as well as the soft palate and lateral pharyngeal wall.
Patent NZ-572644-A (NZ)
Title: T-cell vaccine
Inventor: WILLIAMS JIM C
IPC: A61K39/00
Filed: 2007-05-04
Abstract: Provided is a method of identifying one or more epitopes within a polypeptide antigen for an autoreactive T cell, comprising: (a) providing a sample comprising T cells isolated from a patient; (b) adding one or more different epitopes to a plurality of portions of the sample, wherein the sequences of the epitopes collectively comprise a portion of the sequence of the polypeptide antigen; and (c) identifying the one or more different epitopes that activate the patient's T cells. Further provided is a A method of preparing a personalized T cell vaccine, comprising (a) providing a sample comprising T cells isolated from a patient; (b) contacting the T-cells with one or more different epitopes, whereby autoreactive T cells are activated; (c) expanding activated autoreactive T cells; and (d) attenuating the autoreactive T cells; wherein the one or more different epitopes comprise all epitopes of an antigenic polypeptide capable of stimulating the patient's T cells with a stimulation index above a predetermined value.
Patent NZ-573197-A (NZ)
Title: Headgear assembly for a respiratory mask assembly with rear portion having curved upper strap and intermediate and lower straps
Inventor: LITHGOW PERRY DAVID
IPC: A61M16/06
Filed: 2003-09-05
Abstract: A headgear assembly for use in holding a respiratory mask assembly in position on a patient's face has two side portions, each side portion having an upper side strap and a lower side strap. A rear portion interconnects the two side portions and has an upper curved strap, a lower strap and an intermediate strap arrangement therebetween, with the rear portion further including a stiffener constructed and arranged to maintain the rear portion in a predetermined shape to avoid interference with the patient's ears in use.
Patent NZ-576524-A (NZ)
Title: Crystalline modification of fipronil
Inventor: SAXELL HEIDI EMILIA
IPC: A01N47/02
Filed: 2007-11-05
Abstract: Disclosed is a crystalline modification IV of fipronil which has an X-ray powder diffraction pattern, recorded using Cu-Ka radiation at 25 degrees Cesius, with at least four of the following peaks at two degrees theta: 7.8, 9.8, 11.6, 13.7, 16.8, 19.3, 24.8, 29.4. Processes for preparing the above modification IV of fipronil is disclosed. Use of the composition for treating or controlling pests is also disclosed.
Patent NZ-578832-A (NZ)
Title: A post with a reversable ground engaging washer that prevents vertical movement of the post
Inventor: RICHARDSON MARK FLETCHER
IPC: E04H17/22
Filed: 2009-08-04
Abstract: A ground engaging washer (10) for a post (20) is disclosed. The washer (10) helps prevents vertical movement of the post (20) after it has been installed into the ground. The washer (10) comprises a ground engaging portion and a post engaging portion (12). The ground engaging portion has a substantially planar surface with an outer edge (11) and an internal edge (13). The internal edge defines an opening through which the post (20) is inserted. The post engaging portion (12) is situated along and adjacent the internal edge (13) and is angled relative to the planar surface so that the post engaging portion (12) extends inwardly and in an upward or downward direction away from the internal edge (13). This post engaging portion (12) is adapted to engage with an abutment means (23) on the lower most ground engaging part of the post (20). In use the washer (10) is slid onto the post (20) such that the ground engaging portion extends in a transverse to the longitudinal axis of the post (20) and both are lowered into a hole. The hole is then filled and the soil compacted such that the soil surrounding and covering ground engaging portion prevents the post (20) from moving vertically when the post (20) is under tension. The washer (10) may be positioned relative to the abutment means (22) to prevent upward motion, downward motion or both if two washers (10) are used. The prevention of both motions is achieved by inverting one of the washers (10) relative to the other (10) and sliding them onto the post (20) from opposite ends, both coming to rest on opposite sides of the abutment means (23).
Patent NZ-584241-A (NZ)
Title: Milking parlour comprising a robotic manipulation device which moves with an extendable element
Inventor: DANNEKER GERT
IPC: A01K1/12
Filed: 2008-09-19
Abstract: Disclosed is a milking parlour including a robotic manipulation device with a robot arm and a milking stall provided on a platform moveable relative to the robotic manipulation device. The milking parlour has an extendable element with which the robotic manipulation device is moved. The extendible element is extendable in the direction of movement of the platform so as to prevent the milking stall from moving beyond the reach of the robotic manipulation device too rapidly.
Patent NZ-584638-A (NZ)
Title: Retainng wall block with one orthogonal end wall and one end wall tapering from front to back and mold with orthogonal wall located lowermost
Inventor: MACDONALD ROBERT
IPC: E02D29/02
Filed: 2008-10-16
Abstract: A retaining wall block has a rear flange and a mold box and method of making the block. The mold box is configured with a mold cavity that includes a vertical flange forming cavity extending from the top of the mold box to the bottom of the mold box.
Patent NZ-586109-A (NZ)
Title: New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
Inventor: CACCIAGLIA ROBERTO
IPC: A61K31/165
Filed: 2008-11-12
Abstract: Disclosed are polymeric forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide of Formula (I) having the following peaks at the diffraction degrees (2-theta) in the X-ray powder diffraction pattern plus or minus 0.2: 9.7; 12.0; 18.0; 24.1; 25.9. Also disclosed is polymeric form B having the following peaks at the diffraction degrees (2-theta) in the X-ray powder diffraction pattern plus or minus 0.2: 11.7; 19.8; 22.3; 23.6. Further disclosed is the process for making polymorphic forms A and B, a pharmaceutical composition comprising polymorphs A or B and the use of the Forms A and B in the manufacture of a medicament for treating drug addiction and alcoholism and reducing the voluntary consumption of ethyl alcohol in the treatment of abstinences syndrome.
Patent NZ-589510-A (NZ)
Title: Light duty liquid cleaning compositions and methods of manufacture and use thereof
Inventor: SZEWCZYK GREGORY
IPC: C11D1/94
Filed: 2009-06-17
Abstract: Disclosed is a cleaning composition consisting of: A) a surfactant combination consisting of (i) sodium dodecyl benzene sulfonate (ii) sodium lauryl ether sulfate with about two EO (methacrylic acid (stearyl alcohol-20) units, (iii) laurylamidopropyl betaine, B) at least one organic acid chosen from lactic acid, formic acid, citric acid, sorbic acid, acetic acid, propanoic acid, propionic acid, oxalic acid, maleic acid, tartaric acid, adipic acid, malic acid, malonic acid, and glycolic acid, A method for cleaning a surface comprising contacting a surface with the above composition is also disclosed.